Physician Assistant · Lynwood, CA
NPI
1427503515
Since 2016
Specialty
Physician Assistant
Code 363A00000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
10007 State St
Lynwood, CA, 90262
Phone (323) 566-3157
Medicare paid, 2023
$1,620
31 services
Medicare patients, 2023
19
Average age 71
Drug cost, 2024
$3.0M
9,015 prescriptions
Company payments, 2025
$17K
From 39 companies
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-12-06.
| Medicare paid |
|---|
| 81002 Clinical Chemistry | 16 | 16 | $3.45 | $55.18 |
| 87428 Infectious Agent Detection by DNA/RNA | 12 | 12 | $30.63 | $368 |
Medicare prescription drug claims, 2024
In 2024, the drug Michael Flores prescribed most often to Medicare patients was Atorvastatin Calcium, with 664 prescriptions and refills. In total Michael Flores wrote 9,015 Medicare prescriptions that cost $3.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 664 | 1,736 | 240 | $10K |
| Xarelto Rivaroxaban | 560 | 648 | 112 | $347K |
| Icosapent Ethyl Generic | 325 | 363 | 74 | $59K |
| Nexlizet Bempedoic Acid/Ezetimibe | 321 | 352 | 75 | $135K |
| Repatha Sureclick Evolocumab | 304 | 321 | 60 | $170K |
| Metformin Hcl Generic | 301 | 805 | 112 | $3,354 |
| Farxiga Dapagliflozin Propanediol | 271 | 305 | 65 | $166K |
| Amlodipine Besylate Generic | 270 | 784 | 107 | $2,744 |
| Lisinopril Generic | 228 | 628 | 88 | $2,465 |
| Jardiance Empagliflozin | 208 | 258 | 41 | $147K |
| Kerendia Finerenone | 200 | 222 | 38 | $137K |
| Omeprazole Generic | 176 | 510 | 78 | $2,687 |
| Montelukast Sodium Generic | 174 | 390 | 90 | $2,326 |
| Pioglitazone Hcl Generic | 172 | 484 | 61 | $4,789 |
| Valsartan Generic | 171 | 473 | 59 | $4,934 |
Brand drugs: 3,791 claims; generic drugs: 5,193 claims; opioid claims: 112.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael Flores $17K ($17K in general payments such as food, travel and fees) from 39 companies. The largest payer was Madrigal Pharmaceuticals with $2,896.
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals MDGL | 33 | $2,896 |
| Dexcom, Inc. DXCM | 5 | $2,819 |
| Amgen Inc. AMGN | 31 | $2,111 |
| Medtronic, Inc. MDT | 9 | $1,533 |
| AstraZeneca Pharmaceuticals LP AZN | 21 | $1,151 |
| Abbvie Inc. ABBV | 40 | $1,042 |
| Ardelyx, Inc. ARDX | 14 | $770 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 27 | $556 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 11 | $522 |
| Pfizer Inc. PFE | 19 | $367 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.